BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tang LC, Jin X, Yang HY, He M, Chang H, Shao ZM, Di GH. Luminal B subtype: a key factor for the worse prognosis of young breast cancer patients in China. BMC Cancer. 2015;15:201. [PMID: 25885213 DOI: 10.1186/s12885-015-1207-z] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Wu H, Wang Q, Zhong H, Li L, Zhang Q, Huang Q, Yu Z. Differentially expressed microRNAs in exosomes of patients with breast cancer revealed by next‑generation sequencing. Oncol Rep 2020;43:240-50. [PMID: 31746410 DOI: 10.3892/or.2019.7401] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
2 Villarreal-Garza C, Mohar A, Bargallo-Rocha JE, Lasa-Gonsebatt F, Reynoso-Noverón N, Matus-Santos J, Cabrera P, Arce-Salinas C, Lara-Medina F, Alvarado-Miranda A, Ramírez-Ugalde MT, Soto-Perez-de-Celis E. Molecular Subtypes and Prognosis in Young Mexican Women With Breast Cancer. Clin Breast Cancer 2017;17:e95-e102. [PMID: 28065398 DOI: 10.1016/j.clbc.2016.11.007] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.6] [Reference Citation Analysis]
3 Wang J, Li Q, Zhang P, Yuan P, Ma F, Luo Y, Cai R, Fan Y, Chen S, Li Q, Wang J, Xu B. TNM stage at diagnosis is more predictive of prognosis than pathological complete response in young breast cancer treated with neoadjuvant chemotherapy. Anticancer Drugs 2018;29:176-83. [PMID: 33052637 DOI: 10.1097/CAD.0000000000000577] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Goddard ET, Bassale S, Schedin T, Jindal S, Johnston J, Cabral E, Latour E, Lyons TR, Mori M, Schedin PJ, Borges VF. Association Between Postpartum Breast Cancer Diagnosis and Metastasis and the Clinical Features Underlying Risk. JAMA Netw Open 2019;2:e186997. [PMID: 30646210 DOI: 10.1001/jamanetworkopen.2018.6997] [Cited by in Crossref: 32] [Cited by in F6Publishing: 24] [Article Influence: 16.0] [Reference Citation Analysis]
5 Kudela E, Samec M, Kubatka P, Nachajova M, Laucekova Z, Liskova A, Dokus K, Biringer K, Simova D, Gabonova E, Dankova Z, Biskupska Bodova K, Zubor P, Trog D. Breast Cancer in Young Women: Status Quo and Advanced Disease Management by a Predictive, Preventive, and Personalized Approach. Cancers (Basel) 2019;11:E1791. [PMID: 31739537 DOI: 10.3390/cancers11111791] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 7.5] [Reference Citation Analysis]
6 Rahmawati Y, Setyawati Y, Widodo I, Ghozali A, Purnomosari D. Molecular Subtypes of Indonesian Breast Carcinomas - Lack of Association with Patient Age and Tumor Size. Asian Pac J Cancer Prev 2018;19:161-6. [PMID: 29373908 DOI: 10.22034/APJCP.2018.19.1.161] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
7 Belhadj A, Seddiki S, Belhadj A, Zakmout B, Araba AEKA, Sahraoui T. Prevalence and prognosis of molecular phenotypes in breast cancer patients by age: a population-based retrospective cohort study in western Algeria. Pan Afr Med J 2021;38:88. [PMID: 33889254 DOI: 10.11604/pamj.2021.38.88.21370] [Reference Citation Analysis]
8 Lin H, Zhang F, Wang L, Zeng. Use of clinical nomograms for predicting survival outcomes in young women with breast cancer. Oncol Lett 2019;17:1505-16. [PMID: 30675206 DOI: 10.3892/ol.2018.9772] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
9 Lei YY, Bai S, Chen QQ, Luo XJ, Li DM. Clinical and pathological features and risk factors for primary breast cancer patients. World J Clin Cases 2021;9:5046-53. [PMID: 34307555 DOI: 10.12998/wjcc.v9.i19.5046] [Reference Citation Analysis]
10 Fredholm H, Magnusson K, Lindström LS, Tobin NP, Lindman H, Bergh J, Holmberg L, Pontén F, Frisell J, Fredriksson I. Breast cancer in young women and prognosis: How important are proliferation markers? Eur J Cancer 2017;84:278-89. [PMID: 28844016 DOI: 10.1016/j.ejca.2017.07.044] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
11 Fredholm H, Magnusson K, Lindström LS, Garmo H, Fält SE, Lindman H, Bergh J, Holmberg L, Pontén F, Frisell J, Fredriksson I. Long-term outcome in young women with breast cancer: a population-based study. Breast Cancer Res Treat 2016;160:131-43. [PMID: 27624330 DOI: 10.1007/s10549-016-3983-9] [Cited by in Crossref: 38] [Cited by in F6Publishing: 33] [Article Influence: 7.6] [Reference Citation Analysis]
12 Martinez-Cannon BA, Castro-Sanchez A, Barragan-Carrillo R, de la Rosa Pacheco S, Platas A, Fonseca A, Vega Y, Bojorquez-Velazquez K, Bargallo-Rocha JE, Mohar A, Villarreal-Garza C. Adherence to Adjuvant Tamoxifen in Mexican Young Women with Breast Cancer. Patient Prefer Adherence 2021;15:1039-49. [PMID: 34040357 DOI: 10.2147/PPA.S296747] [Reference Citation Analysis]
13 Wang JM, Wang J, Zhao HG, Liu TT, Wang FY. Reproductive Risk Factors Associated with Breast Cancer Molecular Subtypes among Young Women in Northern China. Biomed Res Int 2020;2020:5931529. [PMID: 32337260 DOI: 10.1155/2020/5931529] [Reference Citation Analysis]
14 Li Y, Lu S, Zhang Y, Wang S, Liu H. Loco-regional recurrence trend and prognosis in young women with breast cancer according to molecular subtypes: analysis of 1099 cases. World J Surg Oncol 2021;19:113. [PMID: 33849563 DOI: 10.1186/s12957-021-02214-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Villarreal-Garza C, Bargallo-Rocha JE, Soto-Perez-de-Celis E, Lasa-Gonsebatt F, Arce-Salinas C, Lara-Medina F, Reynoso-Noverón N, Matus-Santos J, Cabrera P, Alvarado-Miranda A, Mohar A. Real-world outcomes in young women with breast cancer treated with neoadjuvant chemotherapy. Breast Cancer Res Treat 2016;157:385-94. [PMID: 27189008 DOI: 10.1007/s10549-016-3811-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
16 Wang J, Wang J, Li Q, Zhang P, Yuan P, Ma F, Luo Y, Cai R, Fan Y, Chen S, Li Q, Xu B. Young breast cancer patients who develop distant metastasis after surgery have better survival outcomes compared with elderly counterparts. Oncotarget 2017;8:44851-9. [PMID: 28206957 DOI: 10.18632/oncotarget.15268] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
17 Frick E, Gudjonsson T, Eyfjord J, Jonasson J, Tryggvadóttir L, Stefansson O, Sigurdsson S. CpG promoter hypo-methylation and up-regulation of microRNA-190b in hormone receptor-positive breast cancer. Oncotarget 2019;10:4664-78. [DOI: 10.18632/oncotarget.27083] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Zhang X, Yang J, Cai H, Ye Y. Young age is an independent adverse prognostic factor in early stage breast cancer: a population-based study. Cancer Manag Res 2018;10:4005-18. [PMID: 30310322 DOI: 10.2147/CMAR.S167363] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 2.3] [Reference Citation Analysis]
19 Lian W, Fu F, Lin Y, Lu M, Chen B, Yang P, Zeng B, Huang M, Wang C. The Impact of Young Age for Prognosis by Subtype in Women with Early Breast Cancer. Sci Rep 2017;7:11625. [PMID: 28912475 DOI: 10.1038/s41598-017-10414-x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]